Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin concentration in prime solution for pediatric cardiac surgery
IRCT20180522039787N1Phase 3Completed
- Sponsor
- Rajaie Cardiovascular Medical and Research Center
- Start
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, double-blind trial of albumin (human) in Cardiovascular Malformation (CVM) (2 arms), sponsored by Rajaie Cardiovascular Medical and Research Center. Primary endpoint: albumin. Started Mar 2018; status: completed.
02
Drugs
albumin (human)
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on IRCT20180522039787N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180522039787N1.